SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-143978
Filing Date
2024-05-21
Accepted
2024-05-21 16:35:08
Documents
15
Period of Report
2024-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d807530d8k.htm   iXBRL 8-K 24726
2 EX-99.1 d807530dex991.htm EX-99.1 15741
  Complete submission text file 0001193125-24-143978.txt   203551

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20240521.xsd EX-101.SCH 3532
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20240521_def.xml EX-101.DEF 13787
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20240521_lab.xml EX-101.LAB 22468
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20240521_pre.xml EX-101.PRE 14575
18 EXTRACTED XBRL INSTANCE DOCUMENT d807530d8k_htm.xml XML 5572
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 24969978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)